Physician profile
Ashley Haggerty
NPI 1639331028
$7,640.03
in general payments reported to CMS, 2019-2025
19 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 77% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.46 · 2021: $2,088 · 2022: $89.94 · 2023: $3,064 · 2024: $559 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,028 · Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,027.50 |
| Food and Beverage | $1,422.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,834.06 | 2023-2025 | Lynparza |
| Glaxosmithkline, LLC. | $2,003.08 | 2021-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $1,480.01 | 2023-2025 | Keytruda, Lynparza |
| Genmab U.S., INC. | $243.06 | 2022-2025 | Tivdak |
| Davol INC. | $228.12 | 2024-2025 | Arista, Arista Ah Flexitip |
| Myriad Genetic Laboratories, INC. | $177.10 | 2021-2024 | Myrisk |
| Eisai INC. | $144.26 | 2023-2025 | |
| Hologic Sales and Service, LLC | $143.52 | 2022-2025 | Coolseal Generator |
| Janssen Pharmaceuticals, INC | $129.38 | 2024 | Xarelto |
| Abbvie INC. | $50.21 | 2024-2025 | |
| Caris Mpi, INC. | $39.61 | 2025 | Mi Cancer Seek |
| Medtronic, INC. | $31.35 | 2024 | Synchromedii |
| Intuitive Surgical, INC. | $30.47 | 2020-2025 | |
| Ethicon INC. | $23.93 | 2022 | |
| Dilon Technologies, INC. | $23.46 | 2025 | Hemoblast Bellows |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $17.94 | 2023 | Enseal, Echelon Flex |
| Tela Bio, INC. | $14.26 | 2024 | Ovitex 2s |
| Medical Device Business Services, INC. | $13.35 | 2021 | |
| Immunogen, INC. | $12.86 | 2023 | Elahere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Haggerty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.